Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

(2015) A. Forastiero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination ofCandidabiomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment

(2015) M. Carmen Martínez-Jiménez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study

(2015) Matteo Bassetti et al.   PLoS One

Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin

(2014) Fernando César Bizerra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bloodstream Infections Are an Improbable Cause of Positive Serum (1,3)-β-d-Glucan in Hematology Patients

(2014) E. Furfaro et al.   Clinical and Vaccine Immunology

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

(2014) A. Fekkar et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

(2014) Arnaldo L. Colombo et al.   INTENSIVE CARE MEDICINE

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

(2014) Olivier Lortholary et al.   INTENSIVE CARE MEDICINE

Lack of 1-3-B-D-glucan detection in adults with bacteraemia

(2014) Anne Desjardins et al.   MEDICAL MYCOLOGY

Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery

(2014) Jürgen Prattes et al.   MYCOSES

Reliability of serum 1,3-beta-d-glucan assay in patients undergoing renal replacement therapy: a review of the literature

(2014) Juergen Prattes et al.   MYCOSES

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Empirical Fluconazole versus Placebo for Intensive Care Unit Patients

(2013) Mindy G. Schuster   ANNALS OF INTERNAL MEDICINE

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Point-Counterpoint: β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections

(2013) Elitza S. Theel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

(2013) Marcio Nucci et al.   PLoS One

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

(2012) Kimberly E. Hanson et al.   PLoS One

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

(2011) Valerio Del Bono et al.   Clinical and Vaccine Immunology

Early treatment of candidemia in adults: a review

(2010) Luis Ostrosky-Zeichner et al.   MEDICAL MYCOLOGY